Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
DesRosier Thomas
See Remarks at Seres Therapeutics. Filing since 26 Jan 2018.
CIK 0001435744
Company
Date
Role
Action
Shares
Amount
Of holding
MCRB
Seres Therapeutics, Inc.
17 Aug 2026
See Remarks
Sold on a plan
82
$373.10
1.0%
MCRB
Seres Therapeutics, Inc.
18 May 2026
See Remarks
Sold on a plan
79
$594.87
1.0%
MCRB
Seres Therapeutics, Inc.
15 Feb 2026
See Remarks
Sold on a plan
78
$660.66
1.0%
MCRB
Seres Therapeutics, Inc.
15 Nov 2025
See Remarks
Sold on a plan
76
$1.31K
1.0%
MCRB
Seres Therapeutics, Inc.
18 Aug 2025
See Remarks
Sold on a plan
76
$1.27K
1.0%
MCRB
Seres Therapeutics, Inc.
15 May 2025
Chief Legal Officer and EVP
Sold on a plan
79
$575.12
1.1%
MCRB
Seres Therapeutics, Inc.
18 Feb 2025
Chief Legal Officer and EVP
Sold on a plan
4,300
$3.49K
2.9%
MCRB
Seres Therapeutics, Inc.
18 Nov 2024
Chief Legal Officer and EVP
Sold on a plan
878
$474.73
0.6%
MCRB
Seres Therapeutics, Inc.
28 Oct 2024
Chief Legal Officer and EVP
Sold on a plan
4,259
$2.94K
3.1%
MCRB
Seres Therapeutics, Inc.
16 Aug 2024
Chief Legal Officer and EVP
Sold on a plan
873
$733.32
0.7%
MCRB
Seres Therapeutics, Inc.
15 May 2024
Chief Legal Officer and EVP
Sold on a plan
843
$792.42
0.7%
MCRB
Seres Therapeutics, Inc.
16 Feb 2024
Chief Legal Officer and EVP
Sold on a plan
3,939
$4.25K
3.2%
MCRB
Seres Therapeutics, Inc.
30 Oct 2023
Chief Legal Officer and EVP
Sold on a plan
4,156
$5.61K
3.5%
MCRB
Seres Therapeutics, Inc.
28 Jan 2019
Chief Legal Officer and EVP
Sold, plan not stated
5,471
$31.48K
25.4%
MCRB
Seres Therapeutics, Inc.
26 Jan 2018
See Remarks
Sold, plan not stated
3,475
$38.29K
34.8%
15 decisions on file.